Spinal Muscular Atrophy Trial, Recruiting NCT07478172 Sponsor: University of Missouri-Columbia Condition: Spinal Muscular Atrophy
Back to Spinal Muscular Atrophy

Spinal Muscular Atrophy Trial, Recruiting

NCT07478172
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older
  • You have been diagnosed with at least one of the following conditions: ALS (amyotrophic lateral sclerosis), primary lateral sclerosis, progressive muscle atrophy, spinal muscular atrophy, post-polio syndrome, inclusion body myositis, Pompe disease, facioscapulohumeral muscular dystrophy, Charcot-Marie-Tooth disease, chronic inflammatory demyelinating polyneuropathy, hereditary spastic paraplegia, myasthenia gravis, Lambert-Eaton myasthenic syndrome, postural orthostatic tachycardia syndrome, mitochondrial myopathy, nemaline myopathy, centronuclear myopathy, lumbar radiculopathy, or non-specific low back pain
  • You are able to stand continuously for about 15 minutes, with or without a walking aid or other assistive device (for example, long enough to take a shower or prepare a meal)
  • You have at least some ability to move your major muscle groups against gravity, as measured by a standard muscle strength test (confirm with trial site)
  • Your doctor has cleared you to take part in an exercise program
  • You are able to understand and sign a consent form agreeing to take part in the study
  • You are able to meet the study's requirements, such as attending all scheduled visits, keeping your current level of physical activity the same throughout the study, and not planning to move away during the study

Who may not be able to join:

  • You have been diagnosed with Becker muscular dystrophy, Duchenne muscular dystrophy, limb-girdle muscular dystrophy, myotonic dystrophy type 1 or 2, Friedreich's ataxia, or any other neuromuscular condition known or suspected to affect the heart or the structural integrity of muscle fibers
  • You are currently taking part in another research study that involves a treatment or intervention
  • You are unable to stand continuously for 15 minutes, even with the help of an assistive device
  • You have a pacemaker, metal implants, or other implanted medical devices that could affect your safety during a specific type of electrical muscle stimulation used in this study (confirm with trial site)
  • You have a cochlear implant, a brain stimulator (such as a deep brain stimulator or cortical stimulator), a shunt in your brain, a recent opening in your skull, a seizure in the past 12 months while on anti-seizure medication, or a previous serious reaction to a brain scanning technique called TMS (confirm with trial site)
  • You have an unstable ongoing or long-term illness, such as kidney failure, uncontrolled high blood pressure, an irregular heartbeat, a rheumatic disease, or cancer
  • You are known to be pregnant at the time of screening (verbal checks will continue throughout the study)
  • You have a terminal illness and are currently receiving hospice or end-of-life care
  • You have used any medications known to affect muscle size or strength in the past 6 months, such as anabolic steroids, growth hormone, or certain hormone therapies (confirm with trial site for a full list)
  • You have another neurological condition that affects movement or sensation, such as Parkinson's disease, multiple sclerosis, history of stroke, traumatic brain injury, spinal cord injury, or similar conditions
  • You have had a significant bone or joint problem, or surgery in the past year that could affect the results of the exercise portions of the study, such as knee or hip replacement, rotator cuff repair, or spinal fusion
  • You have any other health condition, sign, or symptom that a study investigator determines could interfere with the study or its results

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 573-884-2596

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Missouri-Columbia
Registry
ClinicalTrials.gov
Start date
10 March 2026
Est. completion
31 December 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Mean change from baseline in motor unit firing rates using decomposition electromyography (dEMG); Mean change from baseline in motor evoked potentials using transcranial magnetic stimulation (TMS); Mean change from baseline in compound muscle action potential ampliutde using standard nerve conduction study technique; Mean change from baseline in timed functional tests

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov